Orbimed Advisors - SIERRA ONCOLOGY INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of SIERRA ONCOLOGY INC
ValueSharesWeighting
Q2 2022$108,043,000
+71.6%
1,964,7700.0%1.96%
+91.8%
Q1 2022$62,971,000
+96.1%
1,964,770
+33.0%
1.02%
+147.2%
Q4 2021$32,117,000
-0.8%
1,477,3200.0%0.41%
+16.0%
Q3 2021$32,383,000
+12.6%
1,477,3200.0%0.36%
+22.3%
Q2 2021$28,763,000
+13.0%
1,477,3200.0%0.29%
+22.3%
Q1 2021$25,454,000
+7.5%
1,477,3200.0%0.24%
+15.0%
Q4 2020$23,681,000
+50.2%
1,477,3200.0%0.21%
+4.5%
Q3 2020$15,763,000
-11.8%
1,477,3200.0%0.20%
-21.4%
Q2 2020$17,876,000
+23.2%
1,477,3200.0%0.25%
+3.3%
Q1 2020$14,507,0001,477,3200.24%
Other shareholders
SIERRA ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
CAXTON CORP 443,959$8,645,0005.92%
Vivo Capital, LLC 1,917,074$37,325,0001.62%
SILVERARC CAPITAL MANAGEMENT, LLC 139,305$2,712,0001.21%
Ghost Tree Capital, LLC 200,000$3,894,0001.07%
Ikarian Capital, LLC 545,002$10,628,0000.86%
Nan Fung Group Holdings Ltd 130,979$2,550,0000.79%
Opaleye Management Inc. 165,500$3,222,0000.54%
Sio Capital Management, LLC 93,252$1,816,0000.45%
Rock Springs Capital Management LP 1,018,658$19,833,0000.39%
FRAZIER MANAGEMENT LLC 202,803$3,949,0000.36%
View complete list of SIERRA ONCOLOGY INC shareholders